Bickmann, Julia K.; Sollfrank, Stefanie; Schad, Arno et al.
Phenotypic Variability and Risk of Malignancy in SDHC-Linked Paragangliomas: Lessons From Three Unrelated Cases With an Identical Germline Mutation (p.Arg133*)JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. Bd. 99. H. 3. 2014 S. E489-E496
von Tempelhoff, GF; Heilmann, L; Rudig, L et al.
Mean maternal second-trimester hemoglobin concentration and outcome ofClin Appl Thromb Hemost. Bd. 14. 2008 S. 19-28
Steiner, E; Pollow, K; Hasenvlever, D et al.
Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancerGynecol Oncol. Bd. 108. 2008 S. 569-576
Heilmann, L; Rath, W; Pollow, K
Hemostatic abnormalities in patients with severe preeclamsiaClin Appl Thromb Hemost. Bd. 13. 2007 S. 285-291
Seufert, R; Maltaris, T; Passuello, V et al.
Inhibine und Aktivin A beim PCO SyndromJ Reprod Med. Bd. 4. 2007 S. 257 - 258
Maltaris, T; Seufert, R; Fischl, F et al.
The effect of cancer treatment on female fertility and strategies for preserving fertility.Eur J Obstet Gynecol Reprod Biol. Bd. 130. H. 2. 2007 S. 148-55
Heilmann, L; Rath, W; Pollow, K et al.
The rheological changes after cecarean section: The influence of low moleclar weight or unfractionated hparin on the the rheological properties of bloodClin Hemorheol Micro. Bd. 37. 2007 S. 211-218
Seufert, R; Passuello, V; Schaffrath, M et al.
Kinderwunsch bei PCO-PatientinnenL Fertil Reprod. Bd. 16. H. 2. 2006 S. 22-23
Schaffrath, M; Seufert, R; Harter, P et al.
Ovarian Carcinoma: Clinical Validity bey Simultaneous Determination of Fibrin Degradation Produkts with the DR-70 TM Immunoassay and CA-125Geburtshilfe Frauenheilkd. Bd. 66. 2006 S. 68 -76
Heilmann, L; Wild, C; Hojnacki, B et al.
Successful treatment of life-threatening bleeding after cesarean section with recombinant activated factor VII.Clin Appl Thromb Hemost. Bd. 12. 2006 S. 227-229